Related references
Note: Only part of the references are listed.Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases
Margherita Brindisi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6
Jeremy D. Osko et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Novel 2, 5-diketopiperazine derivatives as potent selective histone deacetylase 6 inhibitors: Rational design, synthesis and antiproliferative activity
Xin Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo
Ritu Ojha et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review
Rajat Sarkar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
A short guide to histone deacetylases including recent progress on class II enzymes
Suk-Youl Park et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
HDAC6 inhibition promotes α-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in mice
Cristina Picci et al.
EXPERIMENTAL NEUROLOGY (2020)
Exploring Structural Determinants of Inhibitor Affinity and Selectivity in Complexes with Histone Deacetylase 6
Jeremy D. Osko et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Structural and in Vivo Characterization of Tubastatin A, a Widely Used Histone Deacetylase 6 Inhibitor
Sida Shen et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
HDAC6 inhibitors: Translating genetic and molecular insights into a therapy for axonal CMT
Elisabeth Rossaert et al.
BRAIN RESEARCH (2020)
Design and Synthesis of Dihydroxamic Acids as HDAC6/8/10 Inhibitors
Michael Morgen et al.
CHEMMEDCHEM (2020)
Inhibition of HDAC6 activity protects dopaminergic neurons from alpha-synuclein toxicity
Laetitia Francelle et al.
SCIENTIFIC REPORTS (2020)
Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation
Surabhi Shukla et al.
FRONTIERS IN PHARMACOLOGY (2020)
Design, synthesis, and biological evaluation of novel nicotinamide derivatives as potential histone deacetylase-3 inhibitors
Mohamed M. S. Hamoud et al.
NEW JOURNAL OF CHEMISTRY (2020)
Designing potential HDAC3 inhibitors to improve memory and learning
Sk. Abdul Amin et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2019)
The selective HDAC6 inhibitor Nexturastat A induces apoptosis, overcomes drug resistance and inhibits tumor growth in multiple myeloma
Xiaoyang Sun et al.
BIOSCIENCE REPORTS (2019)
A novel class of anthraquinone-based HDAC6 inhibitors
Yoojin Song et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Selective vulnerability in α-synucleinopathies
Javier Alegre-Abarrategui et al.
ACTA NEUROPATHOLOGICA (2019)
High-selective HDAC6 inhibitor promotes HDAC6 degradation following autophagy modulation and enhanced antitumor immunity in glioblastoma
Jia-Rong Liu et al.
BIOCHEMICAL PHARMACOLOGY (2019)
HDAC6 and Miro1: Another interaction causing trouble in neurons
Ludo Van Den Bosch
JOURNAL OF CELL BIOLOGY (2019)
Deacetylation of Miro1 by HDAC6 blocks mitochondrial transport and mediates axon growth inhibition
Ashley L. Kalinski et al.
JOURNAL OF CELL BIOLOGY (2019)
Anti-metastatic activity of MPTOG211, a novel HDAC6 inhibitor, in human breast cancer cells in vitro and in vivo
Yi-Ling Hsieh et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)
Design, Synthesis, and Biological Evaluation of 2,4-Imidazolinedione Derivatives as HDAC6 Isoform-Selective Inhibitors
Tao Liang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
The Selective HDAC6 Inhibitor ACY-738 Impacts Memory and Disease Regulation in an Animal Model of Multiple Sclerosis
Patrizia LoPresti
FRONTIERS IN NEUROLOGY (2019)
Structure-activity relationship study of thiazolyl-hydroxamate derivatives as selective histone deacetylase 6 inhibitors
Gibeom Nam et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Discovery of a New Isoxazole-3-hydroxamate-Based Histone Deacetylase 6 Inhibitor SS-208 with Antitumor Activity in Syngeneic Melanoma Mouse Models
Sida Shen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
The Acetylation of Lysine-376 of G3BP1 Regulates RNA Binding and Stress Granule Dynamics
Jozsef Gal et al.
MOLECULAR AND CELLULAR BIOLOGY (2019)
Structural Basis of Catalysis and Inhibition of HDAC6 CD1, the Enigmatic Catalytic Domain of Histone Deacetylase 6
Jeremy D. Osko et al.
BIOCHEMISTRY (2019)
Design, synthesis, biological evaluation and molecular docking study of arylcarboxamido piperidine and piperazine-based hydroxamates as potential HDAC8 inhibitors with promising anticancer activity
Prakruti Trivedi et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Novel Benzohydroxamate-Based Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitors Bearing a Pentaheterocyclic Scaffold: Design, Synthesis, and Biological Evaluation
Barbara Vergani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Quinazolin-2,4-dione-Based Hydroxamic Acids as Selective Histone Deacetylase-6 Inhibitors for Treatment of Non-Small Cell Lung Cancer
Chao-Wu Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors
Katharina Voegerl et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Development of Thiazolidinedione-Based HDAC6 Inhibitors to Overcome Methamphetamine Addiction
Chiranjeev Sharma et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Histone deacetylase 6 (HDAC6) deacetylates extracellular signal-regulated kinase 1 (ERK1) and thereby stimulates ERK1 activity
Jheng-Yu Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
HDAC6 interacts with PTPN1 to enhance melanoma cells progression
Jiaqi Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Entropy as a Driver of Selectivity for Inhibitor Binding to Histone Deacetylase 6
Nicholas J. Porter et al.
BIOCHEMISTRY (2018)
HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease
Veronick Benoy et al.
BRAIN (2018)
Recent advances in the discovery of potent and selective HDAC6 inhibitors
Xiu-Xiu Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Identification and Structure-Activity Relationship of HDAC6 Zinc-Finger Ubiquitin Binding Domain Inhibitors
Renato Ferreira de Freitas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
5-Aroylindoles Act as Selective Histone Deacetylase 6 Inhibitors Ameliorating Alzheimer's Disease Phenotypes
Hsueh-Yun Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Multicomponent Synthesis and Binding Mode of Imidazo[1,2-a]pyridine-Capped Selective HDAC6 Inhibitors
Marcel K. W. Mackwitz et al.
ORGANIC LETTERS (2018)
The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model
Sheng-Jun Fan et al.
CELL DEATH & DISEASE (2018)
Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot-Marie-Tooth neuropathy
Zhongying Mo et al.
NATURE COMMUNICATIONS (2018)
HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches
Nilanjan Adhikari et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Design, synthesis and biological screening of 2-aminobenzamides as selective HDAC3 inhibitors with promising anticancer effects
Prakruti Trivedi et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
The Therapeutic Strategy of HDAC6 Inhibitors in Lymphoproliferative Disease
Maria Cosenza et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Histone deacetylase 6 in cancer
Ting Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Histone Deacetylase 6-Selective Inhibitors and the Influence of Capping Groups on Hydroxamate-Zinc Denticity
Nicholas J. Porter et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d/PI3K/AKT/mTOR and ERK pathways
Jinlin Cao et al.
CELL DEATH & DISEASE (2018)
Discovery of the First-in-Class Dual Histone Deacetylase-Proteasome Inhibitor
Sanil Bhatia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Molecular Basis for the Selective Inhibition of Histone Deacetylase 6 by a Mercaptoacetamide Inhibitor
Nicholas J. Porter et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment
Jiacheng Ma et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia
Kamira Maharaj et al.
BLOOD ADVANCES (2018)
Synthesis of Potent and Selective HDAC6 Inhibitors Bearing a Cyclohexane- or Cycloheptane-Annulated 1,5-Benzothiazepine Scaffold
Rob De Vreese et al.
CHEMISTRY-A EUROPEAN JOURNAL (2017)
Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot-Marie-Tooth Disease
Veronick Benoy et al.
NEUROTHERAPEUTICS (2017)
Selective HDAC inhibition by ACY-241 enhances the activity of paclitaxel in solid tumor models
Pengyu Huang et al.
ONCOTARGET (2017)
Combination of palladium nanoparticles and tubastatin-A potentiates apoptosis in human breast cancer cells: a novel therapeutic approach for cancer
Yu-Guo Yuan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Small Molecule Antagonists of the Interaction between the Histone Deacetylase 6 Zinc-Finger Domain and Ubiquitin
Rachel J. Harding et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors
Nicholas J. Porter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Design and Synthesis of Mercaptoacetamides as Potent, Selective, and Brain Permeable Histone Deacetylase 6 Inhibitors
Wei Lv et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
HDAC6 Brain Mapping with [18F] Bavarostat Enabled by a RuMediated Deoxyfluorination
Martin G. Strebl et al.
ACS CENTRAL SCIENCE (2017)
Enhancement of pomalidomide anti-tumor response with ACY-241, a selective HDAC6 inhibitor
Brian J. North et al.
PLOS ONE (2017)
Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway
Shigeki Saito et al.
PLOS ONE (2017)
Ricolinostat, the First Selective Histone Deacetylase 6 Inhibitor, in Combination with Bortezomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma
Dan T. Vogl et al.
CLINICAL CANCER RESEARCH (2017)
Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine
Maria Cosenza et al.
APOPTOSIS (2017)
Bicyclic-Capped Histone Deacetylase 6 Inhibitors with Improved Activity in a Model of Axonal Charcot-Marie-Tooth Disease
Sida Shen et al.
ACS CHEMICAL NEUROSCIENCE (2016)
Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors
Johanna Senger et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer
Y-W Chang et al.
ONCOGENE (2016)
Dissecting structure-activity-relationships of crebinostat: Brain penetrant HDAC inhibitors for neuroepigenetic regulation
Balaram Ghosh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors
D. Diedrich et al.
CHEMICAL COMMUNICATIONS (2016)
Computer-aided identification of new histone deacetylase 6 selective inhibitor with anti-sepsis activity
Jakyung Yoo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial
Andrew J. Yee et al.
LANCET ONCOLOGY (2016)
HDAC6-mediated EGFR stabilization and activation restrict cell response to sorafenib in non-small cell lung cancer cells
Zhihao Wang et al.
MEDICAL ONCOLOGY (2016)
Essential role of HDAC6 in the regulation of PD-L1 in melanoma
M. Lienlaf et al.
MOLECULAR ONCOLOGY (2016)
STRUCTURAL BIOLOGY HDAC6 finally crystal clear
Yanli Liu et al.
NATURE CHEMICAL BIOLOGY (2016)
Histone deacetylase 6 structure and molecular basis of catalysis and inhibition
Yang Hai et al.
NATURE CHEMICAL BIOLOGY (2016)
Structural insights into HDAC6 tubulin deacetylation and its selective inhibition
Yasuyuki Miyake et al.
NATURE CHEMICAL BIOLOGY (2016)
Isoproterenol increases histone deacetylase 6 expression and cell migration by inhibiting ERK signaling via PKA and Epac pathways in human lung cancer cells
Jeong Ah Lim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
Selective HDAC6 Inhibitor ACY-241, an Oral Tablet, Combined with Pomalidomide and Dexamethasone: Safety and Efficacy of Escalation and Expansion Cohorts in Patients with Relapsed or Relapsed-and-Refractory Multiple Myeloma (ACE-MM-200 Study)
Ruben Niesvizky et al.
BLOOD (2016)
Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China
Xianping Lu et al.
INTRACTABLE & RARE DISEASES RESEARCH (2016)
The role of epigenetics in personalized medicine: challenges and opportunities
Mahmood Rasool et al.
BMC MEDICAL GENOMICS (2015)
Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell death
Yuko Mishima et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Synthesis of benzothiophene-based hydroxamic acids as potent and selective HDAC6 inhibitors
Rob De Vreese et al.
CHEMICAL COMMUNICATIONS (2015)
FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
Hyon-Zu Lee et al.
CLINICAL CANCER RESEARCH (2015)
Design and Synthesis of Orally Bioavailable Aminopyrrolidinone Histone Deacetylase 6 Inhibitors
Xianfeng Lin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation
K. V. Woan et al.
MOLECULAR ONCOLOGY (2015)
Development of a histone deacetylase 6 inhibitor and its biological effects
Ju-Hee Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes
Sin Young Choi et al.
VASCULAR PHARMACOLOGY (2015)
Thiol-Based Potent and Selective HDAC6 Inhibitors Promote Tubulin Acetylation and T-Regulatory Cell Suppressive Function
Mariana C. F. Segretti et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Histone deacetylase 6 in health and disease
Carole Seidel et al.
EPIGENOMICS (2015)
Nuclear HDAC6 inhibits invasion by suppressing NF-κB/MMP2 and is inversely correlated with metastasis of non-small cell lung cancer
Chih-Jen Yang et al.
ONCOTARGET (2015)
MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors
W. A. Gold et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
aPKC Phosphorylation of HDAC6 Results in Increased Deacetylation Activity
Yifeng Du et al.
PLOS ONE (2015)
Oprozomib, Pomalidomide, and Dexamethasone (OPomd) in Patients (Pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Initial Results of a Phase 1 b Study (NCT01999335)
Jatin Shah et al.
BLOOD (2015)
HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers
Preeti Putcha et al.
BREAST CANCER RESEARCH (2015)
Selective Inhibitor of Histone Deacetylase 6 (Tubastatin A) Suppresses Proliferation of Hepatitis C Virus Replicon in Culture of Human Hepatocytes
M. V. Kozlov et al.
BIOCHEMISTRY-MOSCOW (2014)
Identification of a Novel Aminotetralin Class of HDAC6 and HDAC8 Selective Inhibitors
Guozhi Tang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Histone deacetylase 6 regulates cytotoxic α-synuclein accumulation through induction of the heat shock response
Yunlan Du et al.
NEUROBIOLOGY OF AGING (2014)
Antidepressant-Like Properties of Novel HDAC6-Selective Inhibitors with Improved Brain Bioavailability
Jeanine Jochems et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Drugging the HDAC6-HSP90 interplay in malignant cells
Oliver H. Kraemer et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
A selective histone deacetylase-6 inhibitor improves BDNF trafficking in hippocampal neurons from Mecp2 knockout mice: implications for Rett syndrome
Xin Xu et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
Edward Seto et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition
Maj-Linda Selenica et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Potent and selective HDAC6 inhibitory activity of N-(4-hydroxycarbamoylbenzyl)-1,2,4,9-tetrahydro-3-thia-9-azafluorenes as novel sulfur analogues of Tubastatin A
Rob De Vreese et al.
CHEMICAL COMMUNICATIONS (2013)
Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease
Nambirajan Govindarajan et al.
EMBO MOLECULAR MEDICINE (2013)
HDAC6 promotes hepatocellular carcinoma progression by inhibiting P53 transcriptional activity
Gang Ding et al.
FEBS LETTERS (2013)
Genetic syndromes caused by mutations in epigenetic genes
Maria Berdasco et al.
HUMAN GENETICS (2013)
Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects
Santosh Vishwakarma et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
The Role of HDAC6 in Alzheimer's Disease
Ling Zhang et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Extracellular Signal-regulated Kinase (ERK) Phosphorylates Histone Deacetylase 6 (HDAC6) at Serine 1035 to Stimulate Cell Migration
Kendra A. Williams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Potent and Selective Inhibition of Histone Deacetylase 6 (HDAC6) Does Not Require a Surface-Binding Motif
Florence F. Wagner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?
Claudia Simoes-Pires et al.
MOLECULAR NEURODEGENERATION (2013)
Development of a histone deacetylase 6 inhibitor and its biological effects
Ju-Hee Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
Loredana Santo et al.
BLOOD (2012)
Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis
E. Kerr et al.
CELL DEATH AND DIFFERENTIATION (2012)
A novel GRK2/HDAC6 interaction modulates cell spreading and motility
Vanesa Lafarga et al.
EMBO JOURNAL (2012)
Protein Aggregates Are Recruited to Aggresome by Histone Deacetylase 6 via Unanchored Ubiquitin C Termini
Hui Ouyang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth
Joel A. Bergman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
HDAC6 as a target for antileukemic drugs in acute myeloid leukemia
Bjoern Hackanson et al.
LEUKEMIA RESEARCH (2012)
HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease
Constantin d'Ydewalle et al.
NATURE MEDICINE (2011)
Hdac6 Knock-Out Increases Tubulin Acetylation but Does Not Modify Disease Progression in the R6/2 Mouse Model of Huntington's Disease
Anna Bobrowska et al.
PLOS ONE (2011)
Rapid, computer vision-enabled murine screening system identifies neuropharmacological potential of two new mechanisms
Steven L. Roberds et al.
FRONTIERS IN NEUROSCIENCE (2011)
Disease-causing mutations in Parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy
Joo-Yong Lee et al.
JOURNAL OF CELL BIOLOGY (2010)
Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
Kyle V. Butler et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer
Veronica Novotny-Diermayr et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Acetylation of histone deacetylase 6 by p300 attenuates its deacetylase activity
Younho Han et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Function of Histone Deacetylase 6 as a Cofactor of Nuclear Receptor Coregulator LCoR
Ana Palijan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
Michael Haberland et al.
NATURE REVIEWS GENETICS (2009)
Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome
Wen-Xing Ding et al.
AUTOPHAGY (2008)
Effects of downregulated HDAC6 expression on the proliferation of lung cancer cells
Kazuo Kamemura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
HDAC6 a new cellular stress surveillance factor
Patrick Matthias et al.
CELL CYCLE (2008)
Structural origin of selectivity in class II-selective histone deacetylase inhibitors
Guillermina Estiu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Histone deacetylase 6 interacts with the microtubule-associated protein tau
Huiping Ding et al.
JOURNAL OF NEUROCHEMISTRY (2008)
HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation
R. B. Parmigiani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6
James A. Olzmann et al.
JOURNAL OF CELL BIOLOGY (2007)
HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination
C. Boyault et al.
ONCOGENE (2007)
HDAC6 modulates cell motility by altering the acetylation level of cortactin
Xiaohong Zhang et al.
MOLECULAR CELL (2007)
HEF1-Dependent aurora a activation induces disassembly of the primary cilium
Elena N. Pugacheva et al.
CELL (2007)
HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS
Udai Bhan Pandey et al.
NATURE (2007)
HDAC6 deacetylation of tubulin modulates dynamics of cellular adhesions
Andy Dong-Anh Tran et al.
JOURNAL OF CELL SCIENCE (2007)
HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates
Cyril Boyault et al.
GENES & DEVELOPMENT (2007)
FDA approval summary: Vorinostat for treatment of advanced primary cutaneous T-cell lymphoma
Bhupinder S. Mann et al.
ONCOLOGIST (2007)
Characterization of the two catalytic domains in histone deacetylase 6
H Zou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Acetylation and deacetylation of non-histone proteins
MA Glozak et al.
GENE (2005)
HDAC6 and microtubules are required for autophagic degradation of aggregated Huntingtin
A Iwata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Toward selective histone deacetylase inhibitor design: Homology modeling, docking studies, and molecular dynamics simulations of human class I histone deacetylases
DF Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90 - A novel basis for antileukemia activity of histone deacetylase inhibitors
P Bali et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer
S Saji et al.
ONCOGENE (2005)
HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor
JJ Kovacs et al.
MOLECULAR CELL (2005)
Transcriptional regulation by the acetylation of nonhistone proteins in humans - A new target for therapeutics
C Das et al.
IUBMB LIFE (2005)
Epigenetics - An epicenter of gene regulation: Histones and histone-modifying enzymes
M Biel et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Role of the tetradecapeptide repeat domain of human histone deacetylase 6 in cytoplasmic retention
NR Bertos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress
Y Kawaguchi et al.
CELL (2003)
Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation
SJ Haggarty et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Histone deacetylases (HDACs): characterization of the classical HDAC family
AJM De Ruijter et al.
BIOCHEMICAL JOURNAL (2003)
HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo
Y Zhang et al.
EMBO JOURNAL (2003)
NF-κB inhibits transcription of the H+-K+-ATPase α2-subunit gene:: role of histone deacetylases
WZ Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2002)
Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21CIP1/WAF1 promoter
JJ Westendorf et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes
SS Hook et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family
L Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
HDAC6 is a microtubule-associated deacetylase
C Hubbert et al.
NATURE (2002)
Isolation and characterization of mammalian HDAC10, a novel histone deacetylase
HY Kao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Histone acetyltransferases: function, structure, and catalysis
R Marmorstein et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2001)
The human histone deacetylase family
SG Gray et al.
EXPERIMENTAL CELL RESEARCH (2001)
Cloning and characterization of a novel human. Class I histone deacetylase that functions as a transcription repressor
E Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5
XB Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
The language of covalent histone modifications
BD Strahl et al.
NATURE (2000)
Share Paper
